Piedmont Encouraging Donations of Convalescent Plasma From Patients Who Have Recovered From COVID-19
July 22, 2020
July 22, 2020
ATLANTA, Georgia, July 22 -- Piedmont Healthcare issued the following news release:
The need is growing for donations of convalescent plasma, an experimental treatment for COVID-19, as hospitalizations for patients with the disease continue to increase throughout Georgia. Piedmont Healthcare is participating in a U.S. Food and Drug Administration (FDA) expanded access program that involves the donation of plasma, the liquid portion of the blood, from COVID-19 survivors to those curr . . .
The need is growing for donations of convalescent plasma, an experimental treatment for COVID-19, as hospitalizations for patients with the disease continue to increase throughout Georgia. Piedmont Healthcare is participating in a U.S. Food and Drug Administration (FDA) expanded access program that involves the donation of plasma, the liquid portion of the blood, from COVID-19 survivors to those curr . . .